251 related articles for article (PubMed ID: 33273565)
1. Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients.
Lebossé F; Inchauspé A; Locatelli M; Miaglia C; Diederichs A; Fresquet J; Chapus F; Hamed K; Testoni B; Zoulim F
Sci Rep; 2020 Dec; 10(1):21097. PubMed ID: 33273565
[TBL] [Abstract][Full Text] [Related]
2. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
Wong DK; Seto WK; Fung J; Ip P; Huang FY; Lai CL; Yuen MF
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1004-10.e1. PubMed ID: 23376799
[TBL] [Abstract][Full Text] [Related]
3. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
[TBL] [Abstract][Full Text] [Related]
4. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B.
Lai CL; Wong D; Ip P; Kopaniszen M; Seto WK; Fung J; Huang FY; Lee B; Cullaro G; Chong CK; Wu R; Cheng C; Yuen J; Ngai V; Yuen MF
J Hepatol; 2017 Feb; 66(2):275-281. PubMed ID: 27639844
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.
Wong DK; Seto WK; Cheung KS; Chong CK; Huang FY; Fung J; Lai CL; Yuen MF
Liver Int; 2017 Jul; 37(7):995-1001. PubMed ID: 27992681
[TBL] [Abstract][Full Text] [Related]
6. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ
Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694
[TBL] [Abstract][Full Text] [Related]
8. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
Bowden S; Locarnini S; Chang TT; Chao YC; Han KH; Gish RG; de Man RA; Yu M; Llamoso C; Tang H
World J Gastroenterol; 2015 Apr; 21(15):4644-51. PubMed ID: 25914474
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas13-assisted hepatitis B virus covalently closed circular DNA detection.
Zhang X; Tian Y; Xu L; Fan Z; Cao Y; Ma Y; Li H; Ren F
Hepatol Int; 2022 Apr; 16(2):306-315. PubMed ID: 35298777
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfection.
Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Zoulim F; Lacombe K; Boyd A
AIDS; 2020 Nov; 34(13):1943-1949. PubMed ID: 32773480
[TBL] [Abstract][Full Text] [Related]
11. Single hepatocytes show persistence and transcriptional inactivity of hepatitis B.
Balagopal A; Grudda T; Ribeiro RM; Saad YS; Hwang HS; Quinn J; Murphy M; Ward K; Sterling RK; Zhang Y; Perelson AS; Sulkowski MS; Osburn WO; Thio CL
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 33004689
[TBL] [Abstract][Full Text] [Related]
12. An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases.
Piracha ZZ; Saeed U; Kim J; Kwon H; Chwae YJ; Lee HW; Lim JH; Park S; Shin HJ; Kim K
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493816
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA.
Kim ES; Zhou J; Zhang H; Marchetti A; van de Klundert M; Cai D; Yu X; Mitra B; Liu Y; Wang M; Protzer U; Guo H
PLoS Pathog; 2022 Jun; 18(6):e1010576. PubMed ID: 35679251
[TBL] [Abstract][Full Text] [Related]
14. [Comparative analysis of drug resistant mutations in the reverse transcriptase domain of hepatitis B virus covalently closed circular DNA and the viral relax circle DNA].
Su HL; Liu YM; Ren XQ; Xu DP; Zhong YW
Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):818-21. PubMed ID: 21138628
[TBL] [Abstract][Full Text] [Related]
15. HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome.
Yang G; Feng J; Liu Y; Zhao M; Yuan Y; Yuan H; Yun H; Sun M; Bu Y; Liu L; Liu Z; Niu JQ; Yin M; Song X; Miao Z; Lin Z; Zhang X
Theranostics; 2019; 9(24):7345-7358. PubMed ID: 31695772
[No Abstract] [Full Text] [Related]
16. Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR.
Zhong Y; Han J; Zou Z; Liu S; Tang B; Ren X; Li X; Zhao Y; Liu Y; Zhou D; Li W; Zhao J; Xu D
Clin Chim Acta; 2011 Oct; 412(21-22):1905-11. PubMed ID: 21741960
[TBL] [Abstract][Full Text] [Related]
17. HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage.
Wang Y; Li Y; Zai W; Hu K; Zhu Y; Deng Q; Wu M; Li Y; Chen J; Yuan Z
Hepatology; 2022 May; 75(5):1275-1288. PubMed ID: 34779008
[TBL] [Abstract][Full Text] [Related]
18. Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients.
Boyd A; Lacombe K; Lavocat F; Maylin S; Miailhes P; Lascoux-Combe C; Delaugerre C; Girard PM; Zoulim F
J Hepatol; 2016 Oct; 65(4):683-691. PubMed ID: 27210429
[TBL] [Abstract][Full Text] [Related]
19. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases.
Ren JH; Hu JL; Cheng ST; Yu HB; Wong VKW; Law BYK; Yang YF; Huang Y; Liu Y; Chen WX; Cai XF; Tang H; Hu Y; Zhang WL; Liu X; Long QX; Zhou L; Tao NN; Zhou HZ; Yang QX; Ren F; He L; Gong R; Huang AL; Chen J
Hepatology; 2018 Oct; 68(4):1260-1276. PubMed ID: 29624717
[TBL] [Abstract][Full Text] [Related]
20. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach.
Singh P; Kairuz D; Arbuthnot P; Bloom K
World J Gastroenterol; 2021 Jun; 27(23):3182-3207. PubMed ID: 34163105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
